EUR 2.36
(-0.84%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -2.73 Million EUR | 29.99% |
2022 | -3.9 Million EUR | 7.04% |
2021 | -4.19 Million EUR | -12.69% |
2020 | -3.72 Million EUR | -1.62% |
2019 | -3.66 Million EUR | -2321.33% |
2018 | 165.09 Thousand EUR | -56.74% |
2017 | 381.63 Thousand EUR | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -3.08 Million EUR | 0.0% |
2023 Q4 | -2.73 Million EUR | 0.0% |
2023 Q2 | -3.81 Million EUR | 0.0% |
2023 FY | -2.73 Million EUR | 29.99% |
2022 Q2 | -4.91 Million EUR | 0.0% |
2022 Q4 | -3.9 Million EUR | 0.0% |
2022 FY | -3.9 Million EUR | 7.04% |
2021 Q4 | -4.19 Million EUR | 0.0% |
2021 FY | -4.19 Million EUR | -12.69% |
2021 Q2 | -3.89 Million EUR | 0.0% |
2020 Q2 | -3.59 Million EUR | 0.0% |
2020 Q4 | -3.72 Million EUR | 0.0% |
2020 FY | -3.72 Million EUR | -1.62% |
2019 Q2 | -609.2 Thousand EUR | 0.0% |
2019 Q4 | -3.66 Million EUR | 21.45% |
2019 FY | -3.66 Million EUR | -2321.33% |
2019 Q3 | -4.66 Million EUR | -666.39% |
2018 Q4 | 165.09 Thousand EUR | 0.0% |
2018 FY | 165.09 Thousand EUR | -56.74% |
2017 FY | 381.63 Thousand EUR | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Philogen S.p.A. | -720 Thousand EUR | -279.583% |
Ulisse Biomed S.p.A. | -2.29 Million EUR | -19.289% |